These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2807559)

  • 1. [Bronchopulmonary penetration of enoxacin].
    Loos U; Sörgel F; Marklein G; Kraeft H
    Infection; 1989; 17 Suppl 1():S23-4. PubMed ID: 2807559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bronchopulmonary penetration of ciprofloxacin].
    Loos U; Marklein G; Scholl H; Schwabe HK
    Pneumologie; 1990 Feb; 44 Suppl 1():312-3. PubMed ID: 2367402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The penetration of ofloxacin and enoxacin into the alveolar spaces in rats].
    Kato M; Tashiro T; Yoshitomo K; Hayashi Y; Ito G; Yamamoto K; Yamada Y; Takeuchi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Oct; 28(10):1338-43. PubMed ID: 2273663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue penetration and clinical efficacy of enoxacin in respiratory tract infections.
    Wood MJ
    Clin Pharmacokinet; 1989; 16 Suppl 1():38-45. PubMed ID: 2653694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The in vivo penetration of erythromycin into alveolar macrophages].
    Carré P; Piva F; Aerts C; Voisin C; Wallaert B
    Rev Mal Respir; 1990; 7(2):119-22. PubMed ID: 2320782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ofloxacin concentrations in tissues involved in respiratory tract infections.
    Perea EJ
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():55-60. PubMed ID: 2286591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractional processing of sequential bronchoalveolar lavage to separate bronchial and alveolar samples.
    Rennard SI; Ghafouri M; Thompson AB; Linder J; Vaughan W; Jones K; Ertl RF; Christensen K; Prince A; Stahl MG
    Am Rev Respir Dis; 1990 Jan; 141(1):208-17. PubMed ID: 2297178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of enoxacin into bronchial secretions.
    Fong IW; Vandenbroucke A; Simbul M
    Antimicrob Agents Chemother; 1987 May; 31(5):748-51. PubMed ID: 3475036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of enoxacin into lung tissue.
    Newsom SW; Eden CG; Wells FC; Meredith P
    J Antimicrob Chemother; 1989 Jan; 23(1):113-5. PubMed ID: 2745246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of enoxacin into middle ear effusion.
    Sundberg L; Edén T
    Acta Otolaryngol; 1990; 109(5-6):438-43. PubMed ID: 2360450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.
    Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():67-77. PubMed ID: 3162904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of alveolar cells and soluble components in bronchoalveolar lavage fluid from non-smoking aluminium potroom workers.
    Eklund A; Arns R; Blaschke E; Hed J; Hjertquist SO; Larsson K; Löwgren H; Nyström J; Sköld CM; Tornling G
    Br J Ind Med; 1989 Nov; 46(11):782-6. PubMed ID: 2556178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the in vivo penetration of cotrimoxazole in alveolar macrophages].
    Lopez I; Dubar V; Aerts C; Voisin C; Wallaert B
    Pathol Biol (Paris); 1990 Apr; 38(4):286-8. PubMed ID: 2377389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven days.
    Dobbs BR; Gazeley LR; Stewart IA; Edwards IR
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():61-6. PubMed ID: 3162903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enoxacin concentrations in lung tissue].
    Adam D; Präuer H; Sörgel F; Zürcher J
    Infection; 1989; 17 Suppl 1():S21-2. PubMed ID: 2807558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enoxacin concentration in seminal fluid, in prostate secretions and in prostatic adenoma tissue following oral administration or intravenous infusion].
    Naber KG; Sörgel F; Kees F; Schumacher H; Sigl G; Zürcher J; Berger S
    Infection; 1989; 17 Suppl 1():S30-6. PubMed ID: 2478481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of enoxacin into human bronchial mucosa.
    Marlin GE; Braude PD; Whelan AJ; Somogyi AA
    Am Rev Respir Dis; 1986 Dec; 134(6):1209-12. PubMed ID: 3466562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution kinetics of enoxacin and its metabolite oxoenoxacin in excretory fluids of healthy volunteers.
    Jaehde U; Sörgel F; Naber KG; Zürcher J; Schunack W
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2092-7. PubMed ID: 8540722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of drug disposition in the lung.
    Rebuck AS; Braude AC
    Drugs; 1984 Dec; 28(6):544-53. PubMed ID: 6394265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of tissue penetration and clinical efficacy of enoxacin in skin and skin structure infections and in osteomyelitis.
    Pankey GA
    Clin Pharmacokinet; 1989; 16 Suppl 1():46-51. PubMed ID: 2653695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.